Robert Cunney

4.4k total citations
89 papers, 1.7k citations indexed

About

Robert Cunney is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Robert Cunney has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 25 papers in Infectious Diseases and 23 papers in Microbiology. Recurrent topics in Robert Cunney's work include Pneumonia and Respiratory Infections (30 papers), Bacterial Infections and Vaccines (23 papers) and Antibiotic Use and Resistance (17 papers). Robert Cunney is often cited by papers focused on Pneumonia and Respiratory Infections (30 papers), Bacterial Infections and Vaccines (23 papers) and Antibiotic Use and Resistance (17 papers). Robert Cunney collaborates with scholars based in Ireland, United Kingdom and United States. Robert Cunney's co-authors include E.G. Smyth, H. Humphreys, Mary Meehan, Eleanor McNamara, Richard J. Drew, Mary Cafferkey, Ross A. Pennie, Fiona Smaill, Anne Bialachowski and S. Murchan and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Robert Cunney

86 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Cunney Ireland 24 886 527 488 425 242 89 1.7k
Helga Erlendsdóttir Iceland 25 913 1.0× 522 1.0× 224 0.5× 357 0.8× 115 0.5× 69 1.5k
C. Doit France 27 974 1.1× 534 1.0× 687 1.4× 423 1.0× 225 0.9× 89 2.0k
Magnus Arpi Denmark 26 1.0k 1.1× 680 1.3× 619 1.3× 204 0.5× 537 2.2× 113 2.2k
Imad Kassis Israel 23 967 1.1× 648 1.2× 481 1.0× 207 0.5× 186 0.8× 110 2.3k
Inmaculada Grau Spain 23 906 1.0× 377 0.7× 217 0.4× 243 0.6× 150 0.6× 50 1.5k
Natalie McCarthy United States 21 927 1.0× 365 0.7× 210 0.4× 366 0.9× 89 0.4× 49 1.7k
Bart J. M. Vlaminckx Netherlands 22 652 0.7× 604 1.1× 502 1.0× 136 0.3× 112 0.5× 63 1.4k
Anne Vergison Belgium 25 874 1.0× 875 1.7× 322 0.7× 345 0.8× 137 0.6× 47 2.0k
Géraldine Hall United States 19 566 0.6× 622 1.2× 183 0.4× 374 0.9× 184 0.8× 33 1.5k
Andrew J. Daley Australia 25 787 0.9× 547 1.0× 539 1.1× 114 0.3× 177 0.7× 102 2.1k

Countries citing papers authored by Robert Cunney

Since Specialization
Citations

This map shows the geographic impact of Robert Cunney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Cunney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Cunney more than expected).

Fields of papers citing papers by Robert Cunney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Cunney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Cunney. The network helps show where Robert Cunney may publish in the future.

Co-authorship network of co-authors of Robert Cunney

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Cunney. A scholar is included among the top collaborators of Robert Cunney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Cunney. Robert Cunney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wagner, Gernot, Gerald Gartlehner, Kylie Thaler, et al.. (2024). Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis. npj Vaccines. 9(1). 257–257. 3 indexed citations
3.
Humphreys, H., Mary Corcoran, Jolita Mereckiene, Robert Cunney, & Suzanne Cotter. (2023). Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults. Epidemiology and Infection. 151. e27–e27. 3 indexed citations
4.
Hughes, Gerard, et al.. (2022). Use of complexity theory to inform antimicrobial stewardship: a scoping review. Journal of Hospital Infection. 154. 95–103. 2 indexed citations
5.
Corcoran, Mary, Jolita Mereckiene, Suzanne Cotter, et al.. (2021). Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures. Vaccine. 39(35). 5064–5073. 13 indexed citations
6.
7.
Drew, Richard J., Robert Cunney, Susan E. Beekmann, et al.. (2018). Diagnosis and Management of Pediatric Influenza in the Era of Rapid Diagnostics. Journal of the Pediatric Infectious Diseases Society. 9(1). 51–55. 1 indexed citations
8.
O’Sullivan, Catherine, Theresa Lamagni, Darshana Patel, et al.. (2018). Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014–15: a prospective surveillance study. The Lancet Infectious Diseases. 19(1). 83–90. 78 indexed citations
9.
Mulhall, Robert, Désirée E. Bennett, Robert Cunney, et al.. (2018). Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup BNeisseria meningitidisIsolated from 2009 to 2013 in the Republic of Ireland. mSphere. 3(4). 17 indexed citations
10.
Morrissey, Samantha M., Maryke Nielsen, Mary Meehan, et al.. (2017). Group B streptococcal PCR testing in comparison to culture for diagnosis of late onset bacteraemia and meningitis in infants aged 7–90 days: a multi-centre diagnostic accuracy study. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1317–1324. 18 indexed citations
11.
Oza, Ajay, et al.. (2016). Risk-adjusted antibiotic consumption in 34 public acute hospitals in Ireland, 2006 to 2014. Eurosurveillance. 21(32). 1 indexed citations
12.
Stapleton, Patrick J., et al.. (2015). Outbreaks of extended spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units: a systematic review. Archives of Disease in Childhood Fetal & Neonatal. 101(1). 72–78. 86 indexed citations
13.
McElligott, Martha, et al.. (2014). Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines. Vaccine. 32(28). 3495–3500. 16 indexed citations
14.
Creamer, E., Anthony Dolan, Orla Sherlock, et al.. (2010). When are the hands of healthcare workers positive for meticillin-resistant Staphylococcus aureus?. Journal of Hospital Infection. 75(2). 107–111. 35 indexed citations
15.
Johnson, A. P., Mike Sharland, C. M. Goodall, et al.. (2010). Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Archives of Disease in Childhood. 95(10). 781–785. 25 indexed citations
16.
Fitzpatrick, Fidelma, Fiona Roche, Robert Cunney, & H. Humphreys. (2009). Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland. Infection Control and Hospital Epidemiology. 30(3). 277–281. 9 indexed citations
17.
Cunney, Robert, et al.. (2000). An Outbreak of Influenza A in a Neonatal Intensive Care Unit. Infection Control and Hospital Epidemiology. 21(7). 449–454. 124 indexed citations
18.
Cunney, Robert, et al.. (1998). Clostridium difficile colitis associated with chronic renal failure. Nephrology Dialysis Transplantation. 13(11). 2842–2846. 50 indexed citations
19.
Johnson, Alan P., et al.. (1995). Urinary isolates of apramycin-resistantEscherichia coliandKlebsiella pneumoniaefrom Dublin. Epidemiology and Infection. 114(1). 105–112. 15 indexed citations
20.
Austin, O., et al.. (1995). The Beneficial Effects of Immunostimulation in Posttraumatic Sepsis. Journal of Surgical Research. 59(4). 446–449. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helga Erlendsdóttir Breakdown of academic impact, for papers by C. Doit Breakdown of academic impact, for papers by Magnus Arpi Breakdown of academic impact, for papers by Imad Kassis Breakdown of academic impact, for papers by Inmaculada Grau Breakdown of academic impact, for papers by Natalie McCarthy Breakdown of academic impact, for papers by Bart J. M. Vlaminckx Breakdown of academic impact, for papers by Anne Vergison Breakdown of academic impact, for papers by Géraldine Hall Breakdown of academic impact, for papers by Andrew J. Daley
Rankless by CCL
2026